## Most Common Cause of Membranous Nephropathy in India: Idiopathic **High-Yield:** Idiopathic (primary) membranous nephropathy is the most common cause of membranous nephropathy in both Indian and global adult populations, accounting for approximately 60–75% of all membranous nephropathy cases. Secondary causes — including Hepatitis B, SLE, and malignancy — collectively account for the remaining 25–40%. **Key Point:** The question asks for the most common "etiological agent or association" among membranous nephropathy cases overall. Even in India, where HBV prevalence is higher than in Western nations, idiopathic membranous nephropathy (now linked to anti-PLA2R antibodies in ~70–80% of primary cases) remains the predominant form. HBV is the most common *secondary* cause in India, but it does not surpass idiopathic disease in absolute frequency. ### Etiology of Membranous Nephropathy: Frequency Breakdown | Etiology | Frequency (India & globally) | |----------|------------------------------| | Idiopathic (primary, anti-PLA2R+) | ~60–75% of all cases | | Hepatitis B virus (most common secondary cause in India) | ~10–20% of all cases | | SLE (secondary, especially females) | ~5–10% | | Malignancy (age >50) | ~5–10% | **Clinical Pearl:** The discovery of anti-phospholipase A2 receptor (anti-PLA2R) antibodies as the pathogenic antigen in primary membranous nephropathy (Beck et al., NEJM 2009) has reinforced that the majority of membranous nephropathy cases are truly idiopathic/primary. In Indian studies (e.g., Golay et al., CJASN 2017), anti-PLA2R positivity was found in ~65–70% of membranous nephropathy biopsies, confirming idiopathic disease as the dominant category. **Important Distinction:** - **Most common overall cause** → Idiopathic (primary) membranous nephropathy ✅ - **Most common *secondary* cause in India** → Hepatitis B virus **Mnemonic: PLA2R = Primary** — Anti-PLA2R antibodies mark **Primary** (idiopathic) membranous nephropathy, the most common form worldwide including India. ### Diagnostic Approach 1. **Serology:** Screen all patients for anti-PLA2R antibodies (primary MN), HBsAg, anti-HCV, ANA/dsDNA (SLE), and age-appropriate malignancy workup. 2. **Immunofluorescence:** Granular IgG and C3 deposits along the capillary wall (subepithelial). 3. **Electron microscopy:** Subepithelial electron-dense deposits ('spike and dome' appearance on silver stain). 4. **Clinical context:** Anti-PLA2R positivity confirms primary MN; secondary causes must be excluded before labeling a case idiopathic. [cite: Harrison's Principles of Internal Medicine 21e, Ch. 279; Golay V et al., CJASN 2017; Beck LH Jr et al., NEJM 2009; KDIGO Glomerulonephritis Guidelines 2021]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.